The Modesto Bee Local Stock Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ARCA biopharma, Inc. (NQ: )
0.4500 USD  UNCHANGED
Last Price  /  Updated: 8:10 PM EST, Mar 4, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about ARCA biopharma, Inc.
 
Unmet Medical Need in Treatment of Heart Failure Patients with Atrial Fibrillation Highlighted in Articles in Inaugural Issue of JACC: Heart Failure
February 06, 2013
from Business Wire News Releases
Biotech Top Stocks to Watch Arena Pharmaceuticals (NASDAQ:ARNA), Gilead Sciences (NASDAQ:GILD), Arca Biopharma Inc (NASDAQ:ABIO), Dendreon Corp (NASDAQ:DNDN)
February 01, 2013
category Stocks
from TransWorldNews Current Releases
Biotech Companies Attractive Targets for Pharma Companies Looking to Replace Lost Revenues
February 01, 2013
Five Star Equities Provides Stock Research on Arca Biopharma and Hemispherx BioPharma Read More
from Marketwired News Releases
Free Research Reports on ABIO, ANX, HEB and ISIS Issued by the Bedford Report
January 31, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
New Adaptive Phase 3 Trial Planned for GencaroTM in Atrial Fibrillation
January 29, 2013
from Business Wire News Releases
GencaroTM Effect on Reducing Ventricular Arrhythmias Paper Published in Circulation: Arrhythmia and Electrophysiology
January 03, 2013
from Business Wire News Releases
CORRECTING AND REPLACING GencaroTM Cardiovascular Effect on Patients with Atrial Fibrillation Paper Published in European Journal of Heart Failure
December 12, 2012
from Business Wire News Releases
GencaroTM Pharmacogenetic Effect Paper Published in Peer Reviewed Journal PLOS ONE
October 10, 2012
from Business Wire News Releases
ARCA Announces Death of Board Chair Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate
August 16, 2012
from Business Wire News Releases
GencaroTM's Norepinephrine Lowering Likely Contributes to Its Effect in Atrial Fibrillation Prevention
March 26, 2012
from Business Wire News Releases
GencaroTM Atrial Fibrillation Data Selected for Presentation at American College of Cardiology 61st Annual Scientific Session & Expo
March 20, 2012
from Business Wire News Releases
ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient
January 19, 2012
from Business Wire News Releases
CEO of ARCA biopharma to Speak on Use of Biomarkers and Implications of Personalized Medicine at New Paradigms Conference on January 12, 2012
January 05, 2012
from Business Wire News Releases
ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genetic Targeting
December 30, 2011
from Business Wire News Releases
ARCA biopharma Announces Private Placement of $1.75 Million with Institutional Investors
December 22, 2011
from Business Wire News Releases
Stocks Gaining Momentum by Mega Stock Picks are ABIO, BIOF, POSC and XFN
November 17, 2011
from EmailWire.Com Press Releases
GencaroTM Demonstrated 74% Risk Reduction for New Onset Atrial Fibrillation in Heart Failure Patients with Genotype Believed to Be Found in Nearly 50% of Population
November 16, 2011
from Business Wire News Releases
GencaroTM Atrial Fibrillation and Pharmacogenetics Presentations at the American Heart Association Scientific Sessions 2011
November 11, 2011
from Business Wire News Releases
NIRI Elects Derek K. Cole New Board Chairman
September 26, 2011
from Business Wire News Releases
Two GencaroTM Atrial Fibrillation Abstracts Accepted for Presentation at the American Heart Association Scientific Sessions 2011
August 10, 2011
from Business Wire News Releases
ARCA biopharma Announces Planned Expansion of Gencaro Development to Atrial Fibrillation
May 26, 2011
from Business Wire News Releases
CEO of ARCA biopharma to Present Gencaro Development Programs at the European Society of Cardiology’s Heart Failure Congress 2011
May 16, 2011
from Business Wire News Releases
ARCA biopharma Signs Global Rights Agreement with Large Pharma Company for One of ARCA’s Early Stage Assets
May 03, 2011
from Business Wire News Releases
ONTC, ABIO and SNEY are the Daily Market Movers for May 3rd from OTCPicks.com
May 03, 2011
from EmailWire.Com Press Releases
ARCA biopharma Announces $3 Million Equity Offering
April 18, 2011
from Business Wire News Releases
ARCA biopharma Licenses Exclusive Worldwide Rights to Bucindolol Genetic Markers
April 15, 2011
from Business Wire News Releases
BERGER & MONTAGUE, P.C. AND IZARD NOBEL LLP ANNOUNCE A PROPOSED $8,916,666 CLASS ACTION SETTLEMENT AND MOTION FOR ATTORNEYS' FEES & EXPENSES
April 15, 2011
from PR Newswire
CEO of ARCA biopharma to Present at American College of Cardiology 60th Annual Scientific Session and i2 Summit 2011
April 05, 2011
from Business Wire News Releases
CEO of ARCA biopharma to Speak on Cardiovascular Implications of Personalized Medicine at Personalized Medicine Coalition Conference on January 6, 2011
January 05, 2011
from Business Wire News Releases
ARCA biopharma Awarded $489,000 Grant under Qualifying Therapeutic Discovery Project
November 04, 2010
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here